Bachem Holding AG (SWX:BANB)
Switzerland
· Delayed Price · Currency is CHF 54.40
+0.75 (1.40%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Commercial Active Pharmaceutical Ingredients | 327.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commercial Active Pharmaceutical Ingredients Growth | 5.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Medicines Category Development | 234.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Medicines Category Development Growth | 3.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research & Specialties | 43.81M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research & Specialties Growth | 7.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research Chemicals | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Research Chemicals Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| United States | 183.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | 138.66M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Denmark | 112.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland | 75.43M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ireland | 54.11M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom | 40.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe / Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe / Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|